Luis Lasalvia,Brett Fenster,Joyce Schroeder,J. Kern Buckner
申请号：
US14431718
公开号：
US20150253314A1
申请日:
2013.09.27
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Cystatin C (CysC) and Galectin 3 (Gal-3) are biomarkers for pulmonary arterial hypertension (PAH), wherein elevated levels of one or other or both CysC and Gal-3 indicates a likelihood of PAH. Also provided are methods for identifying candidates for pulmonary arterial hypertension treatment and methods for monitoring therapeutic treatments of pulmonary arterial hypertension by monitoring levels of CysC and Gal-3 in the subject undergoing therapy.
